Clinical trial
Combination Chemotherapy With or Without Rituximab in Treating Patients With…
NCT00337246 · Cancer Research UK, Other · Completed
Key facts
| NCT number | NCT00337246 |
|---|---|
| Title | Combination Chemotherapy With or Without Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia |
| Official title | A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) With or Without Rituximab in Previously Treated Chronic Lymphocytic Leukemia |
| Lead sponsor | Cancer Research UK, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | rituximab, cyclophosphamide, fludarabine phosphate, mitoxantrone hydrochloride |
| Enrollment | 56 |
| Start date | Jul 1, 2005 |
| Completion | Mar 1, 2011 |
| First posted | Jun 15, 2006 |
| Last update posted | Aug 2, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: